A r t i c l e s Regulatory T cells (T reg cells) represent a subset of CD4 + T cells with a pivotal role in maintaining peripheral immune tolerance and thus in preventing autoimmunity and chronic inflammation 1 . A hallmark of T reg cells is expression of Foxp3, a master transcription factor required for the differentiation, maintenance and suppressive functions of T reg cells 2 . Genetic deficiency in Foxp3 causes aberrant activation and homeostasis of T cells, which leads to multiorgan inflammation 2 . The suppressive function of T reg cells is mediated through both cell-cell contact and the secretion of immunosuppressive cytokines, including transforming growth factor-β (TGF-β), interleukin 10 (IL-10) and IL- 35 (refs. 1,3) .
T reg cells are generally stable; however, a fraction of these cells may lose Foxp3 expression and undergo phenotypic changes to acquire diverse effector functions under lymphopenic and/or inflammatory conditions [4] [5] [6] [7] [8] [9] [10] . The acquisition of inflammatory effector functions by T reg cells may even occur without loss of Foxp3 expression 7, [11] [12] [13] . Although the mechanisms that mediate the phenotypic conversion of T reg cells are still poorly understood, proinflammatory cytokines have been shown to be involved 7, 14 . Moreover, the stability and suppressive function of T reg cells rely on the expression of SOCS1, which negatively regulates the signaling function of several cytokine receptors 13, 15 . SOCS1 inhibits activation of the transcription factors STAT1 and STAT3, thereby restraining T reg cells from being converted into T H 1-or T H 17-like effector T cells 13 .
. Studies of various in vivo models have demonstrated the conversion of T reg cells into effector T cells that resemble T helper type 1 cells (T H 1 cells), IL-17-producing helper T cells (T H 17 cells) or follicular helper T cells, which seems to contribute to uncontrolled chronic inflammation and autoimmunity
The T cell antigen receptors (TCRs) of T reg cells recognize both self and non-self antigens and seem to be constantly stimulated in vivo 16 . However, how TCR-mediated signaling pathways regulate the stability and suppressive function of T reg cells remains poorly understood. One major TCR-elicited pathway involves the activation of a signaling complex composed of Carma1, Bcl-10, Malt1 and the E2 ubiquitin-conjugating enzyme Ubc13 (ref. 17) . Although mammalian cells express many E2 ubiquitin-conjugating enzymes, Ubc13 is unique in that it specifically conjugates the Lys63 (K63)-linked polyubiquitin chains known to be critical for activation of the IκB (inhibitor of NF-κB) kinase IKK and its downstream transcription factor NF-κB 17 . Thus, a chief function of Ubc13 in conventional T cells is to mediate TCR-stimulated activation of IKK-NF-κB and the homeostasis of peripheral T cells 18, 19 . Studies have demonstrated an important role for the NF-κB-family member c-Rel in the regulation of T reg cell differentiation [20] [21] [22] [23] ; however, whether the Ubc13-IKKregulated signaling pathway has a role in regulating the homeostasis, stability or suppressive function of committed T reg cells is unknown.
Here we studied the role of Ubc13 through conditional ablation of the Ubc13-encoding gene Ube2n. We found that 4 8 2 VOLUME 13 NUMBER 5 MAY 2012 nature immunology A r t i c l e s Ubc13 was dispensable for the survival and homeostasis of T reg cells as well as their in vitro suppressive activity. However, Ubc13 had a pivotal role in maintaining the in vivo immunosuppressive function of T reg cells and in preventing the conversion of T reg cells into T H 1-or T H 17-like effector T cells in a manner dependent on its downstream target IKK. The Ubc13-IKK signaling axis was dispensable for expression of T reg cell signature genes but was required for the expression of specific T reg cell functional factors, including IL-10 and SOCS1. Our findings suggest that the Ubc13-IKK signaling axis is an important part of the signaling program that maintains the stability and immunosuppressive function of T reg cells.
RESULTS

Multiorgan inflammation by T reg cell-specific ablation of Ubc13
To examine the T reg cell-specific function of Ubc13, we generated mice with T reg cell-specific conditional deficiency in Ubc13 by crossing mice with loxP-flanked (floxed) alleles encoding Ubc13 (Ube2n fl/fl mice) 24 with mice that have a bacterial artificial chromosome transgene encoding green fluorescent protein (GFP) and humanized Cre recombinase (hCre) under the control of the Foxp3 promoter (Foxp3-GFP-hCre mice) 25 . We used the resulting Ube2n fl/fl Foxp3 GFP-Cre progeny (called 'Ube2n Treg-KO mice' here) and age-matched Ube2n +/+ Foxp3 GFP-Cre control mice (called 'wild-type' here) for experiments. We confirmed specific deletion of Ube2n in T reg cells, but not in CD4 + conventional T cells, by immunoblot analysis of Ubc13 ( Fig. 1a) . Ube2n Treg-KO mice were born at the expected Mendelian ratios and seemed grossly normal at a young age. However, starting from 8 weeks of age, they weighed less than the age-matched wild-type control mice, a phenotype that became more prominent at 12 weeks of age or older ( Fig. 1b) . This phenotype of Ube2n Treg-KO mice was associated with autoimmune symptoms, including greater size and cellularity of peripheral lymphoid organs ( Fig. 1c and data not shown) and lymphocytic infiltration into many nonlymphoid organs ( Fig. 1d) . These pathological phenotypes were reminiscent of those reported for T reg cell-deficient mice 2 . However, in general, the disease severity of Ube2n Treg-KO mice was milder than that of T reg cell-deficient mice and was not associated with fatality. These findings suggested that Ubc13 may regulate certain aspects of T reg cell function.
Abnormal activation of conventional T cells in Ube2n
Treg-KO mice An important function of T reg cells is to prevent abnormal T cell activation and maintain homeostasis of cells of the immune system. We found that the frequency of CD4 + or CD8 + T cells was lower in the spleen and lymph nodes of the Ube2n Treg-KO mice than in those of wild-type mice (Supplementary Fig. 1a ). However, this was not due to a lower abundance of T cells ( Supplementary Fig. 1b ) but apparently resulted from a larger population of non-T cells (CD4 − CD8 − ) associated with the splenomegaly and lymphadenopathy ( Supplementary Fig. 1a ). We did not detect this abnormality in younger (4-week-old) mice that did not have the abnormal autoimmune phenotype (Supplementary Fig. 1c,d) . The non-T cell population in the older Ube2n Treg-KO mice included mainly B220 + B cells in the mesenteric lymph nodes ( Supplementary Fig. 2a ), but also B220 − CD3 − cells, such as CD11c + and F4/80 + myeloid cells and NK1.1 + natural killer cells, in the spleen (Supplementary Fig. 2b) . To assess T cell homeostasis in Ube2n Treg-KO mice, we quantified memory and naive (Ubc13-sufficient) T cells on the basis of surface expression of the activation markers CD44 and CD62L. In both the spleen and lymph nodes, Ube2n Treg-KO mice had a significantly greater frequency of memory and effector-like (CD44 hi CD62L lo ) CD4 + T cells with a concomitantly lower frequency of naive (CD44 lo CD62L hi ) CD4 + T cells than did wild-type mice ( Fig. 2a,b) . The absolute number of memory and effector-like CD4 + T cells was also significantly greater in Ube2n Treg-KO mice (Fig. 2c) . Consistent with those findings, the Ube2n Treg-KO mice had a significantly greater frequency of T H 1, T H 2 and T H 17 CD4 + effector T cells in the spleen (Fig. 2d) .
Because the intestine is often affected by impaired T reg cell function, we examined the effect of T reg cell-specific ablation of Ubc13 on the frequency of T cells in the lamina propria of this organ. Indeed, the lamina propria of both the small and large intestines of Ube2n Treg-KO mice had a much greater frequency of CD4 + and CD8 + T cells than did that of wild-type mice ( Fig. 2e) . In the CD4 + T cell population of Ube2n Treg-KO mice, there was a significantly greater frequency of T H 17 cells (Fig. 2f) . The large intestine of Ube2n Treg-KO mice also had slightly greater frequency of T H 1 cells, although the small intestine did not ( Fig. 2f) . Thus, loss of Ubc13 in T reg cells impaired the homeostasis of Ubc13-sufficient conventional T cells, which further indicated a role for Ubc13 in regulating the immunosuppressive function of T reg cells. npg Ubc13 is dispensable for T reg cell survival and in vitro function Wild-type and Ube2n Treg-KO mice had a similar frequency of Foxp3 + T reg cells in both the thymus and peripheral lymphoid organs ( Supplementary Fig. 3a,b ), which suggested that Ubc13 was dispensable for T reg cell homeostasis. To further confirm that conclusion, we used Rosa26-YFP Cre reporter mice, which express yellow fluorescent protein (YFP) from the ubiquitous Rosa26 locus in a Cre-dependent manner (called 'R26 YFP mice' here) 26 . The progeny of R26 YFP mice crossed with Foxp3-GFP-hCre mice express YFP specifically in T reg cells 25 . Because GFP was not as bright as YFP (Supplementary Fig. 4 ) and thus GFP would not interfere with the YFP signal during analysis, and because all GFP + cells were YFP + (Supplementary Fig. 4 ), we used either YFP or Foxp3 as a marker for T reg cells in our subsequent analyses. As shown by the Foxp3-staining experiments, young R26 YFP mice and Ube2n Treg-KO R26 YFP mice (the progeny of Ube2n Treg-KO mice and R26 YFP mice) had a similar frequency ( Fig. 3a,b ) and number ( Fig. 3c ) of YFP + T reg cells in all organs of the immune system analyzed. At an older age (10 weeks), Ube2n Treg-KO R26 YFP mice had lower frequency of T reg cells in the spleen than R26 YFP mice had (Fig. 3b) , which was not due to fewer T reg cells ( Fig. 3c ) but was apparently caused by the uncontrolled population expansion of the Ubc13-sufficient conventional T cells ( Fig. 3d) . In vitro assays of T reg cells showed that wild-type and Ubc13-deficient T reg cells had a similar ability to suppress the activation of naive CD4 + T cells ( Fig. 3e) . Thus, unlike Foxp3 deficiency, loss of Ubc13 did not compromise the overall suppressive ability of T reg cells.
Ubc13 is required for T reg cell function in vivo
To examine the in vivo function of T reg cells, we used a wellcharacterized adoptive-transfer approach 27 . The transfer of naive CD45RB hi CD4 + T cells into mice deficient in recombination-activating gene 1 (RAG-1-deficient mice) induced overt autoimmunity, defined by gradual weight loss ( Fig. 4a ), splenomegaly and lymphadenopathy ( Fig. 4b) , a greater frequency of memory and effector-like T cells ( Fig. 4c) and hyperplasia of the colonic mucosa ( Fig. 4d) . The transfer of wild-type T reg cells together with the naive CD45RB hi CD4 + T cells effectively suppressed the autoimmune phenotypes of the naive CD4 + T cells, but the transfer of Ubc13-deficient T reg cells together with the naive CD45RB hi CD4 + T cells did not ( Fig. 4a-d) , which suggested considerable attenuation of the suppressive activity of Ubc13-deficient T reg cells. Thus, although Ubc13 was dispensable for the homeostasis and in vitro activity of T reg cells, Ubc13 was required for the immunosuppressive function of T reg cells in vivo, a finding that explained the autoimmune phenotype of Ube2n Treg-KO mice. When we transferred T reg cells in the absence of naive CD45RB hi CD4 + T cells, we found they did not induce severe loss of body weight; however, in contrast to recipients of wild-type T reg cells, the recipients of Ubc13-deficient T reg cells failed to gain weight during the 5-week period after transfer, indicative of a disease phenotype (Fig. 4e) , and they had splenomegaly coupled with greater spleen cellularity ( Fig. 4f,g) , as well as many more transferred T reg cells, suggestive of abnormal population expansion ( Fig. 4h) . We also detected abnormal population expansion 
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A r t i c l e s of Ubc13-deficient T reg cells when we transferred them together with naive CD45RB hi CD4 + T cells ( Supplementary Fig. 5a ).
As the Ubc13-deficient T reg cells had only slightly less apoptosis ( Supplementary Fig. 5b) , the transferred Ubc13-deficient T reg cells might have had a greater ability to expand their populations. We found that the pathological phenotype induced by Ubc13-deficient T reg cells was efficiently suppressed when they were transferred together with wild-type T reg cells ( Fig. 4e-h) . Collectively, these results indicated that under lymphopenic conditions, the Ubc13-deficient T reg cells may have acquired certain inflammatory functions that were controlled by wild-type T reg cells.
Acquisition of effector function by Ubc13-deficient T reg cells
Studies have suggested that T reg cells may acquire the pathological ability to produce proinflammatory cytokines when functionally perturbed by genetic alterations or environmental conditions 5, 6, 13 . Because of the pathological phenotype of the Ubc13-deficient T reg cells, we sought to determine whether Ubc13 had a role in (Supplementary Fig. 6a ), which suggested stable Foxp3 expression.
In agreement with published studies 5,6,10 , when we adoptively transferred YFP + T reg cells into RAG-1-deficient mice together with wild-type naive CD45RB hi CD4 + T cells, a fraction of the T reg cells lost Foxp3 expression, and this occurred to a similar degree in Ubc13-sufficient T reg cells and Ubc13-deficient T reg cells (Supplementary Fig. 6b ).
Because the conversion of T reg cells into effector-like T cells often occurs without loss of Foxp3 expression 7,11-13 , we next assessed the possible acquisition of effector functions in the transferred T reg cells in the mesenteric lymph nodes. Consistent with the proposal that most T reg cells are stable 6 , only a small fraction of Ubc13-sufficient T reg cells had acquired the ability to produce interferon-γ (IFN-γ) and IL-17 at 10 and 21 d after transfer (Fig. 5a) . However, a much greater frequency of Ubc13-deficient T reg cells had a T H 1-or T H 17-like effector phenotype (Fig. 5a,b) . Some of the converted Ubc13-deficient T reg cells produced both IFN-γ and IL-17 (IFN-γ + IL-17 + ).
We next determined whether the acquisition of an effector phenotype by Ubc13-deficient T reg cells depended on the naive CD4 + T cells transferred together with the Ubc13-deficient T reg cells. Notably, even when transferred alone, Ubc13-deficient T reg cells acquired an effector T cell phenotype (Fig. 5c) , with a large proportion of these mutant T reg cells having an IFN-γ + T H 1-like effector phenotype, although the frequency of IL-17 + or IFN-γ + IL-17 + Ubc13-deficient T reg cells was also greater than that of IL-17 + or IFN-γ + IL-17 + wild-type T reg cells (Fig. 5c) . The acquisition of an effector T cell phenotype by Ubc13-deficient T reg cells was not suppressed by the transfer of wild-type T reg cells together with Ubc13-deficient T reg cells. Instead, wild-type T reg cells promoted the shift of Ubc13-deficient T reg cells from an IFN-γ + phenotype to an IL-17 + or IFN-γ + IL-17 + effector phenotype (Fig. 5c) . We also analyzed Foxp3 expression in the transferred T reg cells. Consistent with a published study 13 , we found that in the absence of naive T cells, the transferred T reg cells had a profound loss of Foxp3, with similar results for wild-type T reg cells and Ubc13deficient T reg cells (Fig. 5d) .
We next determined whether Ubc13-deficient T reg cells acquired an effector phenotype under nontransfer conditions in Ube2n Treg-KO mice at the time of the development of overt autoimmune symptoms ( Fig. 5e) . After gating on either Foxp3 + cells (T reg cells) or YFP + cells (T reg cells and formerly Foxp3 + cells), we detected a fraction of T reg cells that expressed IFN-γ or IL-17 in Ube2n Treg-KO R26 YFP mice but not in R26 YFP mice (Fig. 5e) . Consistent with that, enzyme-linked immunosorbent assay (ELISA) showed that the Ubc13-deficient T reg cells secreted significantly more npg A r t i c l e s IFN-γ and IL-17 than did wild-type T reg cells (Fig. 5f) . Thus, Ubc13 maintained the integrity of T reg cells at steady state. The conversion of T reg cells into T H 17-like cells can be induced in vitro by the proinflammatory cytokine IL-6 or by IL-6 in combination with other cytokines 7, 14 . We found that YFP + T reg cells purified from 6-week-old R26 YFP or Ube2n Treg-KO R26 YFP mice mostly lacked the production of effector cytokines (data not shown). Furthermore, ex vivo activation of purified T reg cells under neutral conditions led to the induction of a small frequency of IL-17-producing cells, which was not much different in Ubc13-sufficient versus Ubc13deficient T reg cells (Fig. 5g) . However, after activation in the presence of IL-6 and TGF-β, Ubc13-deficient T reg cells produced a much greater frequency of T H 17-like cells than did wild-type T reg cells (Fig. 5g,h) . The acquisition of an effector T cell phenotype was not associated with loss of Foxp3. Collectively, these results suggested that Ubc13 deficiency rendered T reg cells sensitive to the acquisition of T H 1-and T H 17-like effector activity under lymphopenic and inflammatory conditions.
IKK mediates the function of Ubc13 in T reg cells
A major signaling function of Ubc13 in T cells is to mediate activation of the IKK-NF-κB signaling pathway stimulated by the TCR and the CD28 coreceptor 18, 19 . Consistent with that, we found that crosslinking of the TCR and CD28 in wild-type T reg cells induced phosphorylation of the NF-κB subunit RelA, a molecular event known to be mediated by IKK2 (IKKβ) 28 , but such crosslinking in Ubc13-deficient T reg cells did not (Fig. 6a) . To determine whether impaired IKK-NF-κB signaling was responsible for the immunosuppressive defect of Ubc13-deficient T reg cells, we restored this pathway through the use of a transgenic mouse with a constitutively active transgene encoding IKK2 (called 'IKK2(CA)' here) under the control of a loxP-flanked stop cassette. In this transgenic system, IKK2(CA) is expressed conditionally in progeny of those mice crossed with mice that have cell-specific expression of Cre 29 . By crossing mice heterozygous for that loxP-flanked IKK2(CA) transgene (IKK2(CA) Tg/+ mice)
with Ube2n Treg-KO mice, we generated age-matched Ube2n +/+ IKK2(CA) Tg/+ Foxp3 GFP-Cre mice (called 'wild-type IKK2(CA) Treg-Tg mice' here) and Ube2n fl/fl IKK2(CA) Tg/+ Foxp3 GFP-Cre (called 'Ube2n Treg-KO IKK2(CA) Treg-Tg mice' here).
T reg cell-specific expression of the IKK2(CA) transgene, on either the wild-type or Ube2n Treg-KO background, did not substantially alter the homeostasis of T reg cells (Supplementary Fig. 7) . However, IKK2(CA) restored the suppressive function of Ubc13deficient T reg cells, as indicated by the finding of fewer memory and effector-like CD4 + T cells in Ube2n Treg-KO IKK2(CA) Treg-Tg mice (Fig. 6b) . T reg cell-specific expression of IKK2(CA) did not appreciably alter the frequency of memory-effector-like T cells in wild-type IKK2(CA) Treg-Tg mice (Fig. 6b) . To determine whether IKK2 was required for T reg cell function, we generated mice with conditional deficiency in IKK2 in T reg cells by crossing mice with loxP-flanked alleles encoding IKK2 (Ikbkb fl/fl ; called 'IKK2 fl/fl ' here) 30 with the Foxp3-GFP-hCre mice 25 , which resulted in IKK2 fl/fl Foxp3 GFP-hCre (called 'IKK2 Treg-KO mice' here) and their age-matched IKK2 +/ + Foxp3 GFP-hCre (control) littermates (called 'wild-type' mice here). As noted for Ube2n Treg-KO mice, IKK2 Treg-KO mice had a much greater frequency (Fig. 6c,d) and number (Fig. 6e) of memory and effector-like T cells in peripheral lymphoid organs than did the wildtype control mice. Furthermore, the frequency of effector CD4 + T cells that produced IL-17 and IFN-γ was much greater in IKK2 Treg-KO mice (Supplementary Fig. 8a,b) . However, as with Ubc13 deficiency (Fig. 3a-d) , loss of IKK2 in T reg cells did not substantially alter T reg cell homeostasis (Supplementary Fig. 9a) . The slightly lower frequency of T reg cells in IKK2 Treg-KO mice might have been due to the population expansion of IKK2-sufficient effector T cells because the absolute number of T reg cells was similar in IKK2-deficient mice and wild-type mice (Supplementary Fig. 9b) . Moreover, the IKK2deficient T reg cells resembled the Ubc13-deficient T reg cells in that they were vulnerable to the acquisition of T H 17-and T H 1-like effector functions in vivo (Supplementary Fig. 10a,b) . These findings suggested an important role for the Ubc13-IKK signaling axis in maintaining the function and stability of T reg cells. To further explore the molecular mechanism by which Ubc13 regulates the function of T reg cells, we examined the effect of T reg cell-specific deletion of Ubc13 on the expression of various T reg cell signature genes. Ubc13 deficiency did not inhibit the expression of a panel of well-characterized T reg cell markers in young (5-week-old) R26 YFP and Ube2n Treg-KO R26 YFP mice (Fig. 7a) .
In older (8-week-old) Ube2n Treg-KO mice, T reg cells had moderately higher expression of several T reg cell markers, including ICOS, OX40, CTLA-4 and GITR (data not shown), probably due to the inflammatory environment in these mice. Because Foxp3 is largely responsible for the expression of these T reg cell markers, this result was consistent with the dispensable role of Ubc13 in the expression of Foxp3. We next used real-time RT-PCR to measure the expression of various genes encoding cytokines involved in the suppressive function and effector conversion of T reg cells. Ubc13-deficient T reg cells expressed Tgfb1 (which encodes TGF-β); however, their expression of Il10 (which encodes IL-10) was attenuated (Fig. 7b) . We further confirmed those results by flow cytometry (Fig. 7c) and ELISA (Fig. 7d) . The IL-10-expression defect of Ubc13-deficient T reg cells was largely 'rescued' by expression of the IKK2(CA) transgene ( Supplementary Fig. 11) , which suggested involvement of the IKK signaling axis. Because signaling via the receptor for IL-10 is important for T reg cell function, particularly in the control of T H 17 cell responses [31] [32] [33] , this finding partially explains the functional impairment of Ubc13-deficient T reg cells.
Another gene substantially affected by Ubc13 deficiency was Socs1 (Fig. 7b) , which encodes SOCS1, known to regulate T reg cell stability and prevent the conversion of T reg cells into T H 1-or T H 17-like effector T cells 13 . SOCS1, as well as its homolog SOCS3, negatively regulates signal transduction stimulated by various cytokines, including IL-6, which stimulates the conversion of T reg cells. Consistent with a published report 34 , SOCS3 expression was very low in both Ubc13-sufficient and Ubc13-deficient T reg cells (data not shown), whereas wild-type T reg cells had abundant expression of SOCS1, but Ubc13-deficient T reg cells did not (Fig. 7b) . Flow cytometry also showed considerable SOCS1 expression in wild-type T reg cells and much lower SOCS1 expression in Ubc13-deficient T reg cells (Fig. 7e) . Furthermore, the expression of Il10 and Socs1 was also lower in IKK2deficient T reg cells (Supplementary Fig. 12) .
The Il10 promoter is known to contain functional binding sites for NF-κB and STAT proteins 35, 36 , whereas the role of NF-κB in Socs1 regulation is less well defined. The Socs1 promoter contains STAT-binding sites and responds to stimulation by IL-6 and IFN-γ 37 . However, optimal induction of SOCS1 in T cells requires synergy of cytokine and TCR signals 38 . SOCS1 is also induced by human T cell leukemia virus type I, which seems to involve activation of IKK-NF-κB 39 . To determine the role of the IKK-NF-κB pathway in SOCS1 expression, we assessed whether the 
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A r t i c l e s T reg cell-specific IKK2(CA) transgene was able to restore SOCS1 expression in Ubc13-deficient T reg cells. SOCS1 expression was mostly restored in T reg cells from Ube2n Treg-KO IKK2(CA) Treg-Tg mice (Fig. 7f) . By analyzing the conserved noncoding sequences of Socs1, we identified a putative NF-κB-binding site that was highly conserved among different species and overlapped a previously identified STAT-binding site to form a putative STAT-NF-κB composite site (Fig. 8a) . In luciferase reporter assays, a wild-type Socs1 promoter was activated by TCR-CD28 stimuli acting in synergy with IFN-γ or IL-6, whereas activation of a Socs1 promoter with a mutated binding site for STAT-NF-κB was impaired (Fig. 8b) . In similar reporter assays, a constitutively active form of STAT3 acted in synergy with constitutively active IKK2 to activate the Socs1 promoter, in a manner dependent on the STAT-NF-κB composite site as well (Fig. 8c) . These findings emphasized an important role for the Ubc13-IKK axis in maintaining expression of IL-10 and SOCS1 in T reg cells and suggested direct involvement of NF-κB in mediating Socs1 induction.
SOCS1 in the modulation of T reg cell stability
To determine whether the lower SOCS1 expression in Ubc13deficient T reg cells contributed to their functional abnormality, we used a SOCS1 mimetic peptide that spans the kinase-inhibitory region (KIR) of SOCS1 (SOCS1-KIR) and is known to effectively inhibit signaling via IL-6 and IFN-γ in vitro and to partially restore SOCS1 function in vivo 15, [40] [41] [42] . The SOCS1-KIR peptide substantially inhibited the conversion of Ubc13-deficient T reg cells to T H 17-like cells in vitro, but the negative control peptide SOCS1-KIR2A (with substitution of alanine for phenylalanine at positions 56 and 59 of SOCS1-KIR) did not ( Fig. 9a) . At the dose used, SOCS1-KIR did not substantially inhibit the conversion of wildtype T reg cells, probably because of the already high concentration of endogenous SOCS1.
We next determined whether SOCS1-KIR was able to 'rescue' the functional defect of Ubc13-deficient T reg cells in vivo through the use of the CD45RB hi T cell-transfer model. RAG-1-deficient mice given adoptive transfer of naive CD45RB hi CD4 + T cells plus Ubc13-deficient T reg cells experienced considerable weight loss (Fig. 9b) . Repeated injection of SOCS1-KIR into these recipient mice substantially, although not completely, prevented their weight loss, but injection of SOCS1-KIR2A did not (Fig. 9b) . Furthermore, injection of SOCS1-KIR also partially inhibited the conversion of Ubc13-deficient T reg cells into inflammatory effector T cells in vivo, but injection of SOCS1-KIR2A did not (Fig. 9c) . Although direct suppression of effector T cells may have accounted for the in vivo effect of SOCS1-KIR, these results indicated a role for Ubc13-mediated expression of SOCS1 in the maintenance of T reg cell stability. Because Ubc13 is the main E2 enzyme that conjugates K63-linked ubiquitin chains, this finding further emphasizes a role for K63-linked ubiquitination in T reg cell function. We found that T reg cell-specific ablation of Ubc13 impaired the in vivo immunosuppressive function of T reg cells, causing aberrant activation and homeostasis of conventional T cells and multiorgan inflammation. Unlike most other known regulators of T reg cells, Ubc13 was dispensable for maintaining the expression of Foxp3 and various T reg cell signature genes. Consistent with that, the autoimmune disease of the Ube2n Treg-KO mice was relatively milder than that of scurfy mice (which have a loss-of-function mutation in Foxp3) or Foxp3-deficient mice that completely lack T reg cells 2 . This phenotype suggested that Ubc13 regulates specific aspects of T reg cell functions rather than controlling the overall suppressive activity of T reg cells. Our data suggested that Ubc13 has an important role in preventing the conversion of T reg cells into T H 1-or T H 17-like effector T cells under lymphopenic conditions. The transfer of T reg cells into RAG-1deficient mice, either alone or together with naive CD45RB hi CD4 + T cells, induced a large portion of Ubc13-deficient T reg cells to acquire the ability to produce the proinflammatory cytokines IL-17 and IFN-γ, in contrast to such induction of only a small fraction of transferred wild-type cells. Moreover, the acquisition of effector-like functions by Ubc13-deficient T reg cells occurred without loss of Foxp3 expression, which distinguishes Ubc13 from the known Foxp3-regulatory factors. We believe that the Ubc13 signaling pathway maintains T reg cell stability by diminishing the sensitivity of T reg cells to environmental factors. Under inflammatory conditions, a fraction of Foxp3 + T reg cells can simultaneously express effector T cell cytokines, particularly IL- 17 (refs. 7,11,12,43) . Such findings suggest that proinflammatory cytokines may partially over-ride the inhibitory function of Foxp3. In support of that idea, we found that activation of T reg cells in vitro in the presence of IL-6 and TGF-β induced the production of Foxp3 + IL-17 + T cells. Thus, Ubc13-deficient T reg cells were more sensitive than wild-type cells to cytokine-induced conversion in vitro.
A major downstream signaling molecule of Ubc13 is IKK [17] [18] [19] . It is possible that mitogen-activated protein kinases, known to be regulated by Ubc13 (ref. 19) , are also involved in this, but both gainof-function studies and loss-of-function studies suggest an important role for the IKK pathway downstream Ubc13. Although published studies have suggested a role for IKK-NF-κB in regulating Foxp3 expression and T reg cell development, they have not addressed the role of IKK-NF-κB in regulating the stability and functionality of committed T reg cells [20] [21] [22] [23] . Our data suggested that the Ubc13-IKK signaling axis induced specific genes encoding molecules involved in the regulation of T reg cell stability and function. We have identified Il10 and Socs1 as two important genes regulated by this pathway.
Our findings suggested Socs1 was a direct target gene of the Ubc13-IKK signaling axis that was synergistically transactivated by STAT proteins and NF-κB in T reg cells. Evidence suggests that Il10 may also be a gene that is cooperatively regulated by STAT proteins and NF-κB. A published study has identified an NF-κB-binding sequence in the mouse Il10 promoter (from position −54 to position −43; TGCCAGGAAGGCCCC) 35 . We noted that this NF-κB site overlapped a previously identified STAT-binding site (from position −54 to position −46; TGCCAGGAA) 36 . These studies suggest the involvement of both NF-κB and STAT proteins in the induction of Il10 expression, although it remains to be determined whether this putative STAT-NF-κB composite site is required for the induction of Il10 by TCR-CD28 or by TCR-CD28 in combination with cytokines 35, 36 . Given the importance of T reg cell-derived IL-10 in mediating the in vivo function of T reg cells, especially in the suppression of T H 17 cells 31, 33 , the lower IL-10 expression may have contributed to the impaired in vivo function of Ubc13-deficient T reg cells. Future studies should address whether the Ubc13-IKK signaling pathway mediates the expression of additional genes encoding molecules involved in the stability and function of T reg cells.
In conclusion, we have presented genetic evidence for involvement of the Ubc13-IKK signaling axis in the control of T reg cell stability and function. We propose that Ubc13-IKK regulates the expression of specific molecules involved in the suppressive function and phenotypic stabilization of T reg cells. Our findings provide new insight into the signaling mechanisms that mediate T reg cell function and also suggest Ubc13 as a possible therapeutic target for the pharmacological manipulation of T reg cell function.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
